The advantages of therapeutic antibodies over chemotherapeutics

We caught up with Dr. Sahar Mohseni Nodehi, a scientist at The Antibody Society, at the annual Antibody Engineering and Therapeutics conference in San Diego. where she shared her insights on the advantages of therapeutic antibodies.

"Therapeutic antibodies have several advantages over chemotherapeutics. Usually chemotherapeutic targets are fast dividing cells and that means they can target other cells, which also divide fast rather than cancer cells. But therapeutic antibodies usually target specific antigens on the specific cells.

It’s important that we find and choose a very good antigen or antibody that targets only that antigen. It means we need specific binding between antigen and antibody. Also we need the antigen that is expressed only on tumour cells."

Watch the full interview below:

The annual Antibody Engineering and Therapeutics Europe is taking place in Amsterdam on 5-7 June 2018. Book before 16 February to save up to £300. Find out more or book here.